APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults

Completed · Not applicable · Has a placebo group

Conditions studied: Foot Ulcer, Diabetic

In brief

This is a 10-week, randomized, controlled study to evaluate the efficacy and safety of the APT001 plasma and nitric oxide treatment in subjects with a diabetic foot ulcer.

Key facts

Study ID
NCT02356835
Run by
Origin Inc.
People needed
10
Starts
2015-02-01
Expected to finish
2016-03-01
Last updated by the study team
2016-03-17

Who can join

Age: 19 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.